UK: MRSA Bloodstream Infections Continue To Fall

The Health Protection Agency has today published its latest quarterly report on MRSA (methicillin-resistant Staphylococcus aureus) bloodstream infections.

The Health Protection Agency has today published its latest quarterly report on MRSA (methicillin-resistant Staphylococcus aureus) bloodstream infections.

The latest figures from the Agency's mandatory surveillance of MRSA bloodstream infections show that there were 676 cases reported in England during the October to December quarter of 2008. This represents a 7% decrease on the previous quarter (July to September 2008) when 725 reports were received and a 38% reduction in the corresponding quarter of 2007 (October to December 2007) when 1,092 reports were received.

Source: 

Health Protection Agency

Continue reading ...

Opexa's Stem Cell Therapy For Diabetes Shows Progress

Opexa's Stem Cell Therapy For Diabetes Shows Progress
Opexa Therapeutics, Inc. (NASDAQ: OPXA), a company dedicated to the development of stem cell therapies for diabetes announced new preclinical data to support its autologous stem cell therapy program. Opexa completed confirmatory studies within its c-GMP facility showing that cells obtained from peripheral blood have the ability to differentiate into stem cells and ultimately into pancreatic-like cells.